NCT03435185

Greater Occipital and Supraorbital Nerve Blockade in Migraine Patients

Greater Occipital and Supraorbital Nerve Blockade For The Preventive Treatment of Migraine

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 103 (actual)
• Sponsor: Dr. Lutfi Kirdar Kartal Training and Research Hospital · Other Government
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The investigators aimed to evaluate the efficacy of greater occipital nerve and supraorbital nerve blockade with local anesthetics for the preventive treatment of migraine without aura.

Detailed description

A mixture of 1 ml 2% lidocaine and 0.9% 1 ml saline was injected bilaterally to GON and SON in the blockade patients. Placebo patients received 2 ml 0.9% saline in the same way. Patients were blinded to kind of injection.

Conditions

• Migraine Disorders

Interventions

Type	Name	Description
PROCEDURE	Lidocaine injections	Lidocaine injections. A mixture of 1 ml 2% lidocaine and 0.9% 1 ml saline was injected bilaterally to greater occipital nerve and supraorbital nerve in the blockade patients.
PROCEDURE	Saline injections	Saline injections. Patients received 2 ml 0.9% saline in bilaterally to greater occipital nerve and supraorbital nerve

Timeline

• Start date: 2014-09-01
• Primary completion: 2015-06-01
• Completion: 2016-06-01
• First posted: 2018-02-15
• Last updated: 2022-03-23
• Results posted: 2019-07-22